Paladin Labs Newswire

Paladin Labs Newswire

Comprehensive Real-Time News Feed for Paladin Labs.

Results 1 - 17 of 17 in Paladin Labs

  1. Veloxis Pharmaceuticals A/S and Endo Ventures Limited Jointly...Read the original story w/Photo

    Sunday Jun 4 | GlobeNewswire

    Veloxis Pharmaceuticals A/S and Endo Ventures Limited Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Envarsus XRA in Canada COPENHAGAN, DENMARK & DUBLIN, IRELAND- -- Veloxis Pharmaceuticals A/S today announced that its U.S. subsidiary, Veloxis Pharmaceuticals, Inc., and Endo Ventures Limited have entered into an exclusive license, supply and distribution agreement, to register, commercialize and distribute Envarsus XR Envarsus XRA is a novel, once-daily formulation of tacrolimus for the prophylaxis of organ rejection in kidney transplant patients. Envarsus XR A is currently approved in Europe and the United States.

    Comment?

  2. Knight Reports Fourth Quarter and Year-Ended December 31, 2016 ResultsRead the original story

    Dec 31, 2016 | World News Report

    ... equivalents and marketable securities and 142,713,489 common shares outstanding. Terminated the agreement with Paladin Labs Inc. related to the distribution and sale of ImpavidoA in all countries other than the U.S. Issued secured loans of US$23,000 ...

    Comment?

  3. Profound appoints Desautels alumna to its Board of DirectorsRead the original story w/Photo

    Mar 8, 2017 | McGill University

    ... Desautels Faculty Advisory Board and serves as President of Knight Therapeutics. Prior to that, she was CFO of Paladin Labs, which she helped sell to Dublin-based pharma giant, Endo International. Ms. Sakhia's appointment to the Board comes on the ...

    Comment?

  4. Knight Therapeutics eyes assets from debt-strapped Valeant, EndoRead the original story w/Photo

    Dec 4, 2016 | The Globe and Mail

    ... International Inc. and Endo International PLC. The Montreal drug distributor, launched by former Paladin Labs founder Jonathan Goodman, is keen to acquire Valeant's Canadian sales operation in its entirety or in chunks, Mr. Goodman said Friday. ...

    Comment?

  5. UPDATE 2-Endo's profit, revenue top estimates on strong generic drug salesRead the original story w/Photo

    Nov 8, 2016 | Reuters

    ... bowel drug, and the company cut its full-year profit and revenue forecasts. The company has discussed a sale of Paladin Labs Inc, its Montreal-based specialty pharmaceutical unit, to Canadian drug maker Knight Therapeutics Inc ( Johnson Controls Inc ...

    Comment?

  6. Cuba, Unilever start work on joint soap and toothpaste factoryRead the original story w/Photo

    Nov 4, 2016 | Reuters

    ... have gathered in Brussels for a three-day tasting contest. Nov 4 Endo International Plc has discussed a sale of Paladin Labs Inc, its Montreal-based specialty pharmaceutical subsidiary, to Canadian drug maker Knight Therapeutics Inc, people familiar ...

    Comment?

  7. EXCLUSIVE-Endo considers sale of Paladin Labs to Knight Therapeutics -sourcesRead the original story w/Photo

    Nov 4, 2016 | Reuters

    ) has discussed a sale of Paladin Labs Inc, its Montreal-based specialty pharmaceutical subsidiary, to Canadian drug maker Knight Therapeutics Inc ( The potential deal would help Endo, which has been struggling to cope with pressure on drug prices, ...

    Comment?

  8. Construction group St Gobain to buy Asian group E-MixRead the original story w/Photo

    Mar 2, 2016 | Reuters

    Saint Gobain said the deal would be based on a price of 160 million Singapore dollars , representing 6.6 times E-Mix's 2015 adjusted EBITDA . Endo International Plc has discussed a sale of Paladin Labs Inc, its Montreal-based specialty pharmaceutical subsidiary, to Canadian drug maker Knight Therapeutics Inc , people familiar with the matter said on Friday.

    Comment?

  9. People on the MoveRead the original story

    Oct 6, 2016 | McGill University

    Samira Sakhia , president of Knight Therapeutics, has joined Crescita Therapeutics Inc.'s board of directors. Prior to her current role, she was the chief financial officer of Paladin Labs.

    Comment?

  10. Crescita Therapeutics Announces Changes to the Board of DirectorsRead the original story

    Sep 30, 2016 | McGill University

    ... has joined its board of directors. Prior to her current role, Ms. Sakhia was the Chief Financial Officer of Paladin Labs. Ms. Sakhia holds a Bachelor of Commerce degree in Finance and Accounting and a Masters of Business Administration in Strategy ...

    Comment?

  11. Crescita Therapeutics(TM) Announces Changes to the Board of DirectorsRead the original story w/Photo

    Sep 29, 2016 | Freshnews

    ... has joined its board of directors. Prior to her current role, Ms. Sakhia was the Chief Financial Officer of Paladin Labs. Ms. Sakhia holds a Bachelor of Commerce degree in Finance and Accounting and a Masters of Business Administration in Strategy ...

    Comment?

  12. How Many Times Can Knight Therapeutics Issue Equity?Read the original story w/Photo

    Sep 22, 2016 | Seeking Alpha

    ... small-cap pharmaceutical company. It is led by Jonathan Goodman - famous for his capital allocation prowess at Paladin Labs - and, as of last month, Samira Sakhia, the former CFO at Paladin and new President of Knight. Paladin's history is legendary ...

    Comment?

  13. People on the MoveRead the original story

    Sep 13, 2016 | McGill University

    ... Samira Sakhia , former CFO of Paladin Labs Inc. , has joined the Knight Therapeutics Inc. team as president and as member of the company's board of directors. Ms. Sakhia served as the CFO at Paladin (acquired by Endo International plc February ...

    Comment?

  14. Thursday's TSX breakouts: This stock has 9 'buy' calls and...Read the original story w/Photo

    Sep 1, 2016 | The Globe and Mail

    ... is a pharmaceutical company founded in 2014 by Jonathan Goodman, the previous chief executive and co-founder of Paladin Labs, which was acquired by Endo Health Solutions. Prior to being acquired, Paladin's stock price enjoyed a stellar rally owing ...

    Comment?

  15. A Knight is RebornRead the original story

    Aug 19, 2016 | McGill University

    Knight Therapeutics Inc. , a leading Canadian specialty pharmaceutical company, today announced that Samira Sakhia, former CFO of Paladin Labs Inc. , will be joining the Knight team as President and member of the Board of Directors. In her new role, beginning on August 31, 2016, Samira will report to Jonathan Ross Goodman, CEO of Knight.

    Comment?

  16. A Knight is RebornRead the original story w/Photo

    Aug 17, 2016 | Market Wire

    Knight Therapeutics Inc. , a leading Canadian specialty pharmaceutical company, today announced that Samira Sakhia, former CFO of Paladin Labs Inc. , will be joining the Knight team as President and member of the Board of Directors. In her new role, beginning on August 31, 2016, Samira will report to Jonathan Ross Goodman, CEO of Knight.

    Comment?

  17. Former Paladin Labs Inc. CFO Named President at Knight TherapeuticsRead the original story

    Aug 16, 2016 | BioSpace

    A Knight is Reborn MONTREAL, CANADA-- - Knight Therapeutics Inc. , a leading Canadian specialty pharmaceutical company, today announced that Samira Sakhia, former CFO of Paladin Labs Inc. , will be joining the Knight team as President and member of the Board of Directors. In her new role, beginning on August 31, 2016, Samira will report to Jonathan Ross Goodman, CEO of Knight.

    Comment?